| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |